Experimental induction of amyloidosis by bovine amyloid fibrils in Sore Hock rabbits

References

• Westermark P, Araki S, Benson M D, Cohen A S, Frangione B, Masters C L, Saraiva M J, Sipe J D, Husby G, Kyle R A, Selkoe D. Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8–9, 1998. Part 1. Amyloid: Int J Exp Clin Invest 1999; 6: 63–66
   Google Scholar
• Robert K. Amyloidosis. Pathology1st ed., R Emanuel, L F John. J. B. Lippincott Company, Philadelphia 1988; 1178–1193
   Google Scholar
• Skinner M, Shirahama T, Benson M D, Cohen A S. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977; 36: 420–427
   PubMed Web of Science ®Google Scholar
• Jacob W. Spontaneous amyloidosis of mammals. Vet Pathol 1971; 8: 292–306
   Google Scholar
• Landman W J, Gruys E, Gielkens A L. Avian amyloidosis. Avian Pathol 1998; 27: 437–449
   PubMed Web of Science ®Google Scholar
• Ram J S, Glener G G, DeLellis R A. Amyloid. I. Use of Freund's adjuvant in experimental amyloidosis. Proc Soc Exp Biol Med 1968; 127: 854–856
   PubMedGoogle Scholar
• Janigan D T, Druet R L. Experimental amyloidosis. Role of antigenicity and rapid induction. Am J Pathol 1966; 48: 1013–1025
   Google Scholar
• McAdam K P, Sipe J D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976; 144: 1121–1127
   PubMed Web of Science ®Google Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Yokota T, Takahashi M, Ishihara T, Yamashita Y, Gondo T, Kawamura S, Hoshii Y, Koga M, Iwata T, Uchino F. Amyloid enhancing factor (AEF). Isolation and biochemical and pathological characteristics. Acta Pathol Jpn 1991; 41: 798–805
   PubMedGoogle Scholar
• Kisilevsky R, Gruys E, Shirahama T. Does amyloid enhancing factor (AEF) exits? Is AEF a single biological entity? Amyloid. Int J Exp Clin Invest 1995; 2: 128–133
   Google Scholar
• Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 1994; 199: 306–312
   PubMed Web of Science ®Google Scholar
• Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95: 2558–2563
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Lemieux L, Boudreau L, Yang D S, Fraser P. New clothes for amyloid enhancing factor (AEF): silk as AEF. Amyloid: Int J Exp Clin Invest 1999; 6: 98–106
   PubMed Web of Science ®Google Scholar
• Baltz M L, Capsi D, Hind C R, Feinstein A, Pepys M B. Isolation and characterization of amyloid enhancing factor (AEF). Amyloidosis1st ed., G G Glenner, E F Osserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Press, New York 1986; 115–121
   Google Scholar
• Varga J, Flinn M S, Shirahama T, Rodgers O G, Cohen A S. The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 51: 177–185
   Google Scholar
• Lundmark K, Westermark G T, Nystrom S, Murphy C L, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002; 99: 6979–6984
   PubMed Web of Science ®Google Scholar
• Ali-Khan Z, Quirion R, Robitaille Y, Alizadeh-Khiavi K, Du T. Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract. Acta Neuropathol (Berl) 1988; 77: 82–90
   PubMed Web of Science ®Google Scholar
• Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, Gondo T, Ishihara T. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species. Pathol Int 2002; 52: 40–45
   PubMed Web of Science ®Google Scholar
• Tojo K, Tokuda T, Hoshii Y, Fu X, Higuchi K, Matsui T, Kametani F, Ikeda S. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid: J Protein Folding Disord 2005; 12: 103–108
   PubMed Web of Science ®Google Scholar
• Yamada M, Kotani Y, Nakamura K, Kobayashi Y, Horiuchi N, Doi T, Suzuki S, Sato N, Kanno T, Matsui T. Immunohistochemical distribution of amyloid deposits in 25 cows diagnosed with systemic AA amyloidosis. J Vet Med Sci 2006; 68: 725–729
   PubMed Web of Science ®Google Scholar
• Kraus A L, Weisbroth S H, Flatt R E, Brewer N. Biology and diseases of rabbits. Laboratory Animal Medicine1st ed., J G Fox, B J Cohen, F M Loew. Academic Press, New York 1984; 207–240
   Google Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin E C. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–933
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991; 70: 246–256
   PubMed Web of Science ®Google Scholar
• Esteve V, Almirall J, Ponz E, Garcia N, Ribera L, Larrosa M, Andreu X, Garcia M. Renal involvement in amyloidosis. Clinical outcomes, evolution and survival. Nefrología 2006; 26: 212–217
   Google Scholar
• Eskens U, Burski B, Geisthovel E. Secondary amyloidosis in white Peking ducks. Tierarztl Prax 1984; 12: 469–475
   PubMedGoogle Scholar
• Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomaki H. Amyloidosis – incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993; 22: 158–161
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, Fujishima M. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996; 35: 44–49
   PubMedGoogle Scholar